Advertisement

Management of Acute Ischemic Stroke

Published:October 25, 2018DOI:https://doi.org/10.1016/j.amjmed.2018.10.019

      Abstract

      The treatment of acute ischemic stroke includes both intravenous (IV) thrombolysis and mechanical thrombectomy. Important advances regarding both treatment modalities have occurred recently that all physicians who see patients at risk for or who have had a stroke should be aware of. This review will focus on recent clinical trials of IV thrombolysis both positive and negative. Additionally, the results of a large number of early and late time window thrombectomy trials will be presented that demonstrate the remarkable efficacy of this treatment for appropriately selected patients.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The American Journal of Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Goyal M
        • Menon BK
        • van Zwam WH
        • et al.
        Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials.
        Lancet. 2016; 387: 1723-1731
        • Nogueira RG
        • Jadhav AP
        • Haussen DC
        • et al.
        Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct.
        N Engl J Med. 2018; 378: 11-21
        • Albers GW
        • Marks MP
        • Kemp S
        • et al.
        Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging.
        N Engl J Med. 2018; 378: 708-718
        • National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group
        Tissue plasminogen activator for acute ischemic stroke.
        N Engl J Med. 1995; 333: 1581-1587
        • Hacke W
        • Kaste M
        • Bluhmki E
        • et al.
        Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke.
        N Engl J Med. 2008; 359: 1317-1329
        • Thomalla G
        • Simonsen CZ
        • Boutitie F
        • et al.
        MRI-guided thrombolysis for stroke with unknown time of onset.
        N Engl J Med. 2018; 379: 611-622
        • Ingall TJ
        • O'Fallon WM
        • Asplund K
        • et al.
        Findings from the reanalysis of the NINDS tissue plasminogen activator for acute ischemic stroke treatment trial.
        Stroke. 2004; 35: 2418-2424
        • Sharma VK
        • Ng KW
        • Venketasubramanian N
        • et al.
        Current status of intravenous thrombolysis for acute ischemic stroke in Asia.
        Int J Stroke. 2011; 6: 523-530
        • Anderson CS
        • Robinson T
        • Lindley RI
        • et al.
        Low-dose versus standard-dose intravenous alteplase in acute ischemic stroke.
        N Engl J Med. 2016; 374: 2313-2323
        • Khatri P
        • Kleindorfer DO
        • Devlin T
        • et al.
        Effect of alteplase vs aspirin on functional outcome for patients with acute ischemic stroke and minor nondisabling neurologic deficits: the PRISMS randomized clinical trial.
        JAMA. 2018; 320: 156-166
        • Paoni NF
        • Keyt BA
        • Refino CJ
        • et al.
        A slow clearing, fibrin-specific, PAI-1 resistant variant of t-PA (T103N, KHRR 296-299 AAAA).
        Thromb Haemost. 1993; 70: 307-312
        • Parsons M
        • Spratt N
        • Bivard A
        • et al.
        A randomized trial of tenecteplase versus alteplase for acute ischemic stroke.
        N Engl J Med. 2012; 366: 1099-1107
        • Logallo N
        • Novotny V
        • Assmus J
        • et al.
        Tenecteplase versus alteplase for management of acute ischaemic stroke (NOR-TEST): a phase 3, randomised, open-label, blinded endpoint trial.
        Lancet Neurol. 2017; 16: 781-788
        • Campbell BCV
        • Mitchell PJ
        • Churilov L
        • et al.
        Tenecteplase versus alteplase before thrombectomy for ischemic stroke.
        N Engl J Med. 2018; 378: 1573-1582
        • Berkhemer OA
        • Fransen PS
        • Beumer D
        • et al.
        A randomized trial of intraarterial treatment for acute ischemic stroke.
        N Engl J Med. 2015; 372: 11-20
        • Saver JL
        • Goyal M
        • Bonafe A
        • et al.
        Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke.
        N Engl J Med. 2015; 372: 2285-2295
        • Campbell BC
        • Mitchell PJ
        • Kleinig TJ
        • et al.
        Endovascular therapy for ischemic stroke with perfusion-imaging selection.
        N Engl J Med. 2015; 372: 1009-1018
        • Jovin TG
        • Chamorro A
        • Cobo E
        • et al.
        Thrombectomy within 8 hours after symptom onset in ischemic stroke.
        N Engl J Med. 2015; 372: 2296-2306
        • Goyal M
        • Demchuk AM
        • Menon BK
        • et al.
        Randomized assessment of rapid endovascular treatment of ischemic stroke.
        N Engl J Med. 2015; 372: 1019-1030
        • Powers WJ
        • Derdeyn CP
        • Biller J
        • et al.
        2015 American Heart Association/American Stroke Association Focused Update of the 2013 Guidelines for the Early Management of Patients With Acute Ischemic Stroke Regarding Endovascular Treatment: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association.
        Stroke. 2015; 46: 3020-3035
        • Powers WJ
        • Rabinstein AA
        • Ackerson T
        • et al.
        2018. Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association.
        Stroke. 2018; 49: e46-e110
        • Albers GW
        Late window paradox.
        Stroke. 2018; 49: 768-771
        • Mueller-Kronast NH
        • Zaidat OO
        • Froehler MT
        • et al.
        Systematic evaluation of patients treated with neurothrombectomy devices for acute ischemic stroke: primary results of the STRATIS Registry.
        Stroke. 2017; 48: 2760-2768
        • Zaidat OO
        • Castonguay AC
        • Gupta R
        • et al.
        North American Solitaire Stent Retriever Acute Stroke registry: post-marketing revascularization and clinical outcome results.
        J Neurointerv Surg. 2014; 6: 584-588
        • Zi W
        • Wang H
        • Yang D
        • et al.
        Clinical effectiveness and safety outcomes of endovascular treatment for acute anterior circulation ischemic stroke in China.
        Cerebrovasc Dis. 2017; 44: 248-258
        • Chandra RV
        • Leslie-Mazwi TM
        • Mehta BP
        • et al.
        Does the use of IV tPA in the current era of rapid and predictable recanalization by mechanical embolectomy represent good value.
        J Neurointerv Surg. 2016; 8: 443-446
        • Abilleira S
        • Ribera A
        • Cardona P
        • et al.
        Outcomes after direct thrombectomy or combined intravenous and endovascular treatment are not different.
        Stroke. 2017; 48: 375-378
        • Wang H
        • Zi W
        • Hao Y
        • et al.
        Direct endovascular treatment: an alternative for bridging therapy in anterior circulation large-vessel occlusion stroke.
        Eur J Neurol. 2017; 24: 935-943
        • Kaesmacher J
        • Mordasini P
        • Arnold M
        • et al.
        Direct mechanical thrombectomy in tPA-ineligible and -eligible patients versus the bridging approach: a meta-analysis.
        J Neurointerv Surg. 2018; 10: 625-628
        • Schonenberger S
        • Uhlmann L
        • Hacke W
        • et al.
        Effect of conscious sedation vs general anesthesia on early neurological improvement among patients with ischemic stroke undergoing endovascular thrombectomy: a randomized clinical trial.
        JAMA. 2016; 316: 1986-1996
        • Löwhagen Hendén P
        • Rentzos A
        • Karlsson JE
        • et al.
        General anesthesia versus conscious sedation for endovascular treatment of acute ischemic stroke: the AnStroke Trial (Anesthesia During Stroke).
        Stroke. 2017; 48: 1601-1607
        • Simonsen CZ
        • Yoo AJ
        • Sorensen LH
        • et al.
        Effect of general anesthesia and conscious sedation during endovascular therapy on infarct growth and clinical outcomes in acute ischemic stroke: a randomized clinical trial.
        JAMA Neurol. 2018; 75: 470-477
        • Kang DH
        • Jung C
        • Yoon W
        • et al.
        Endovascular thrombectomy for acute basilar artery occlusion: a multicenter retrospective observational study.
        J Am Heart Assoc. 2018; 7:e009419: 1-9